Absci Corp: ARK Investment Management LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
ARK Investment Management LLC amended its Schedule 13G filing on Absci Corp, updating its disclosed stake in the company with the SEC under accession number 0001104659-26-126821. The filing reflects ARK's current beneficial ownership position in the synthetic biology company. The exact size and percentage of the amended stake were not specified in the headline disclosure. Investors will watch for further detail on whether ARK increased or trimmed its position.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
ARK Investment Management LLC, Absci Corp